Radiodermatitis Market Set for Exponential Growth, Predicted to Surpass USD 609.68 million by 2027

Allied Market Research recently published a report, titled, "Radiodermatitis Market by Product (Topical, Oral Drugs, and Dressings) and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2019-2027". As per the report, the global radiodermatitis industry was pegged at USD 477.48 million in 2019 and is anticipated to reach USD 609.68 million by 2027, growing at a CAGR of 4.1% from 2020 to 2027.

The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.

𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨:

• After the Covid-19 outbreak, the patients with cancers are regarded as a high-risk group as they require hospital visits for radiation therapy.
• However, the demand for radiodermatitis is expected to decline during the pandemic, due to various manufacturers in radiodermatitis have been facing issues in the supply of their products.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞:
https://www.alliedmarketresearch.com/request-sample/4498

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐑𝐞𝐜𝐞𝐧𝐭 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐑𝐚𝐝𝐢𝐨𝐝𝐞𝐫𝐦𝐚𝐭𝐢𝐭𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭?

Major factors that contribute to the market growth include increase in prevalence of cancer and rise in adoption of radiotherapy for treatment globally. In addition, increase in geriatric population further fuels growth of the radiodermatitis market. However, high cost associated with radiodermatitis treatment is anticipated to restrict growth of the market. On the contrary, increase in demand for reduction of side effects associated with radiation therapy is expected to offer lucrative opportunities for the market expansion during the forecast period.

𝐓𝐨𝐩 𝐑𝐚𝐝𝐢𝐨𝐝𝐞𝐫𝐦𝐚𝐭𝐢𝐭𝐢𝐬 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

• Bausch Health Companies Inc
• 3M Company
• BMG Pharma SPA
• Bayer Ag
• Glaxosmithkline Plc
• Convatec Group Plc
• Molnlycke Health Care
• Helsinn Healthcare SA
• Smith & Nephew Plc
• Mylan N.V.
• Stratpharma Ag.

𝐑𝐚𝐝𝐢𝐨𝐝𝐞𝐫𝐦𝐚𝐭𝐢𝐭𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: -

By product, the topical segment held the lion's share in 2019, accounting for more than four-fifths of the global radiodermatitis market, owing to easier application, cost-effectiveness, and its bioavailability. However, the dressing segment is expected to register the highest CAGR of 5.0% during the forecast period, due to presence of a wide range of dressing products in the market and rise in demand for advanced wound care options.

By distribution channel, the online pharmacy segment is expected to manifest the highest CAGR of 5.0% during the forecast period, due to inconvenience for patients, in terms of home delivery of products to purchase medicines from retail or hospital pharmacy. However, the retail pharmacy segment held the largest share in 2019, contributing to more than three-fifths of the global radiodermatitis market, owing to availability of affordable product options, near store locality, and availability of the generic form of drugs.

By region, the market across North America is expected to register the highest CAGR of 5.1% during the forecast period, owing to the inclusion of radiodermatitis products in reimbursement healthcare policy, rise in number of cancer patients, surge in demand for radiation therapy, and high expenditure in the healthcare sector. However, the global radiodermatitis market across Asia-Pacific held the largest share in 2019, accounting for more than two-fifths of the market, due to rise in disposable income, increase in expenditure on healthcare, rise in prevalence of cancer patients, and growth in adoption of advanced healthcare products.

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/4498

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.